<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04747288</url>
  </required_header>
  <id_info>
    <org_study_id>2020-12-014BC</org_study_id>
    <nct_id>NCT04747288</nct_id>
  </id_info>
  <brief_title>Objective Measurement With TCM Pattern for AIDDES</brief_title>
  <official_title>Using the Objective Measurement Methods to Evaluate the Association With TCM Pattern and TCM Tongue Diagnosis for Autoimmune Disease and Dry Eye Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Veterans General Hospital, Taiwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Veterans General Hospital, Taiwan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the association with TCM pattern and TCM tongue diagnosis for Autoimmune disease&#xD;
      and Dry eye syndrome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To explore the association with TCM pattern and TCM tongue diagnosis for&#xD;
      Autoimmune disease and Dry eye syndrome.&#xD;
&#xD;
      Method:&#xD;
&#xD;
      This study wants to include the 1000 Autoimmune disease (AID) subjects as 800 Sjögren's&#xD;
      syndrome (SJS) and 200 Systemic lupus erythematosus (SLE) for comparing with the 500 Dry eye&#xD;
      syndrome (DES) subjects. AID and DES subjects will be enrolled to evaluate at V1 Baseline and&#xD;
      follow-up for 6 times evaluation with one month interval during one year. And the&#xD;
      non-AID-non-DES healthy control subjects will be also included in our study for comparison&#xD;
      with the dry eye syndrome and healthy control. This study want to use objective measurement&#xD;
      and questionnaires as TCM pattern, OSDI, ESSPRI, SF-36, Schirmer's test, TCM heart rate&#xD;
      variability, and TCM tongue diagnosis to differentiate AID, DES and healthy control.&#xD;
&#xD;
      Expected Results:&#xD;
&#xD;
        1. To evaluate the difference among TCM pattern, OSDI, ESSPRI, SF-36, Schirmer's test, TCM&#xD;
           heart rate variability, and TCM tongue diagnosis to differentiate between AID and DES.&#xD;
&#xD;
        2. To evaluate the difference among TCM pattern and TCM tongue diagnosis among the AID&#xD;
           groups, DES group, and healthy control.&#xD;
&#xD;
      Keyword: Autoimmune disease, Sjögren's syndrome, Systemic lupus erythematosus, Dry eye&#xD;
      syndrome, TCM pattern, TCM tongue diagnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>TCM pattern</measure>
    <time_frame>One year</time_frame>
    <description>TCM pattern is a tool for detecting the constitution among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Dry eye syndrome (DES), and healthy control.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TCM tongue diagnosis</measure>
    <time_frame>One year</time_frame>
    <description>TCM tongue diagnosis is a tool for detecting tongue expression among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Dry eye syndrome (DES), and healthy control.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart rate variability (HRV)</measure>
    <time_frame>One year</time_frame>
    <description>Heart rate variability (HRV) is a tool for detecting ratio between High-frequency (HF) activity and low-frequency (LF) activity among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE),and Dry eye syndrome (DES).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer's test</measure>
    <time_frame>One year</time_frame>
    <description>Schirmer's test is a tool for evaluating aqueous tear production among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), and Dry eye syndrome (DES).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>OSDI(Ocular Surface Disease Index)</measure>
    <time_frame>One year</time_frame>
    <description>OSDI is a tool to rate the severity of dry eye disease among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), and Dry eye syndrome (DES).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ESSPRI(EULAR Sjögren's Syndrome Patient Reported Index)</measure>
    <time_frame>One year</time_frame>
    <description>ESSPRI is a tool for evaluating the symptoms of SJS among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), and Dry eye syndrome (DES).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SF-36(36-Item Short Form Survey )</measure>
    <time_frame>One year</time_frame>
    <description>SF-36 is a tool for evaluating Health-Related Quality of Life among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), and Dry eye syndrome (DES).</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">1800</enrollment>
  <condition>Sjögren's Syndrome</condition>
  <condition>Systemic Lupus Erythematosus</condition>
  <condition>Dry Eye Syndrome</condition>
  <arm_group>
    <arm_group_label>Sjögren's syndrome</arm_group_label>
    <description>Sjögren's syndrome patients were screened in the rheumatology outpatient departments and Center for Traditional Medicine at Taipei Veterans General Hospital, and were enrolled with the inclusion criteria: (1) aged between 20 and 75 years; (2) fulfilled the 2002 American-European Consensus Criteria for SS (AECG). Exclusion Criteria: NA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Systemic lupus erythematosus</arm_group_label>
    <description>Systemic lupus erythematosus patients were screened in the rheumatology outpatient departments and Center for Traditional Medicine at Taipei Veterans General Hospital, and were enrolled with the inclusion criteria: (1) aged between 20 and 75 years; (2) fulfilled the 1982 and 1997 revised Systemic lupus erythematosus criteria. Exclusion Criteria: NA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dry eye syndrome</arm_group_label>
    <description>Dry eye syndrome patients were screened in the ophthalmology outpatient departments, rheumatology outpatient departments and Center for Traditional Medicine at Taipei Veterans General Hospital, and were enrolled with the inclusion criteria: (1) aged between 20 and 75 years; (2) Schirmer's test less than 10 mm/5 min. Exclusion Criteria: NA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non AIDDES Healthy Controls</arm_group_label>
    <description>Non AIDDES Healthy Controls were enrolled with inclusion criteria: (1) aged between 20 and 75 years; (2) without any Chronic disease. Exclusion Criteria: any Sjögren's syndrome, Systemic lupus erythematosus, or Dry eye syndrome.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Traditional Chinese Medicine pattern</intervention_name>
    <description>Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE) for comparing with the Dry eye syndrome (DES) and non AIDDES Healthy Controls subjects will take the Traditional Chinese Medicine pattern diagnosis.</description>
    <arm_group_label>Dry eye syndrome</arm_group_label>
    <arm_group_label>Sjögren's syndrome</arm_group_label>
    <arm_group_label>Systemic lupus erythematosus</arm_group_label>
    <arm_group_label>non AIDDES Healthy Controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Traditional Chinese Medicine tongue diagnosis</intervention_name>
    <description>Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE) for comparing with the Dry eye syndrome (DES) and non AIDDES Healthy Controls subjects will take the Traditional Chinese Medicine tongue diagnosis.</description>
    <arm_group_label>Dry eye syndrome</arm_group_label>
    <arm_group_label>Sjögren's syndrome</arm_group_label>
    <arm_group_label>Systemic lupus erythematosus</arm_group_label>
    <arm_group_label>non AIDDES Healthy Controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Heart rate variability</intervention_name>
    <description>Autoimmune disease (AID) as Sjögren's syndrome (SJS) and Systemic lupus erythematosus (SLE) for comparing with the Dry eye syndrome (DES) subjects will take the Heart rate variability.</description>
    <arm_group_label>Dry eye syndrome</arm_group_label>
    <arm_group_label>Sjögren's syndrome</arm_group_label>
    <arm_group_label>Systemic lupus erythematosus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Schirmer's test</intervention_name>
    <description>Autoimmune disease (AID) as Sjögren's syndrome (SJS) and Systemic lupus erythematosus (SLE) for comparing with the Dry eye syndrome (DES) subjects will take the Schirmer's test.</description>
    <arm_group_label>Dry eye syndrome</arm_group_label>
    <arm_group_label>Sjögren's syndrome</arm_group_label>
    <arm_group_label>Systemic lupus erythematosus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ocular Surface Diseast Index (OSDI)</intervention_name>
    <description>Autoimmune disease (AID) as Sjögren's syndrome (SJS) and Systemic lupus erythematosus (SLE) for comparing with the Dry eye syndrome (DES) subjects will take the Ocular Surface Diseast Index (OSDI).</description>
    <arm_group_label>Dry eye syndrome</arm_group_label>
    <arm_group_label>Sjögren's syndrome</arm_group_label>
    <arm_group_label>Systemic lupus erythematosus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)</intervention_name>
    <description>Autoimmune disease (AID) as Sjögren's syndrome (SJS) and Systemic lupus erythematosus (SLE) for comparing with the Dry eye syndrome (DES) subjects will take the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI).</description>
    <arm_group_label>Dry eye syndrome</arm_group_label>
    <arm_group_label>Sjögren's syndrome</arm_group_label>
    <arm_group_label>Systemic lupus erythematosus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>36-Item Short Form Survey (SF-36)</intervention_name>
    <description>Autoimmune disease (AID) as Sjögren's syndrome (SJS) and Systemic lupus erythematosus (SLE) for comparing with the Dry eye syndrome (DES) subjects will take the 36-Item Short Form Survey (SF-36).</description>
    <arm_group_label>Dry eye syndrome</arm_group_label>
    <arm_group_label>Sjögren's syndrome</arm_group_label>
    <arm_group_label>Systemic lupus erythematosus</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Autoimmune disease (AID) as Sjögren's syndrome (SJS), and Dry eye syndrome (DES) subjects&#xD;
        were screened in the ophthalmology outpatient departments, rheumatology outpatient&#xD;
        departments and Center for Traditional Medicine at Taipei Veterans General Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Sjögren's syndrome&#xD;
&#xD;
          -  Inclusion Criteria:&#xD;
&#xD;
               1. aged between 20 and 75 years&#xD;
&#xD;
               2. fulfilled the 2002 American-European Consensus Criteria for SS (AECG)&#xD;
&#xD;
          -  Exclusion Criteria: NA&#xD;
&#xD;
        Systemic lupus erythematosus&#xD;
&#xD;
          -  Inclusion Criteria:&#xD;
&#xD;
               1. aged between 20 and 75 years&#xD;
&#xD;
               2. fulfilled the 1982 and 1997 ACR revised Systemic lupus erythematosus criteria&#xD;
&#xD;
          -  Exclusion Criteria: NA&#xD;
&#xD;
        Dry eye syndrome&#xD;
&#xD;
          -  Inclusion Criteria:&#xD;
&#xD;
               1. aged between 20 and 75 years&#xD;
&#xD;
               2. Schirmer's test less than 10 mm/5 min&#xD;
&#xD;
          -  Exclusion Criteria: NA&#xD;
&#xD;
        non AIDDES Healthy Controls&#xD;
&#xD;
          -  Inclusion Criteria:&#xD;
&#xD;
               1. aged between 20 and 75 years&#xD;
&#xD;
               2. without any Chronic disease&#xD;
&#xD;
          -  Exclusion Criteria: any Sjögren's syndrome, Systemic lupus erythematosus, or Dry eye&#xD;
             syndrome.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chang Ching-Mao, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taipei Veterans General Hospital, Taiwan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chang Ching-Mao, M.D., Ph.D.</last_name>
    <phone>886-28757453 Ext. 333</phone>
    <email>magicbjp@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ching-Mao Chang</name>
      <address>
        <city>Taipei</city>
        <zip>112</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chang Ching-Mao, M.D., Ph.D.</last_name>
      <phone>88628757453 Ext. 333</phone>
      <email>magicbjp@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 9, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2021</study_first_posted>
  <last_update_submitted>May 4, 2021</last_update_submitted>
  <last_update_submitted_qc>May 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sjögren's syndrome</keyword>
  <keyword>Systemic Lupus Erythematosus</keyword>
  <keyword>Dry Eye Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

